Cancer.Net is pleased to offer its patient information on cancer research, treatment, coping, and many other topics in an audio podcast format. This gives people with cancer, and their families and friends, an additional option of how they'd like to receive oncologist-approved information from Cancer.Net.
The Cancer.Net Podcasts series has been awarded a Merit Award in the Digital Health Awards (PDF) competition, which recognizes high-quality digital health resources for consumers and health professionals. The awards are organized by the Health Information Resource Center.
A Cancer.Net Podcast is a pre-recorded audio file in which a specific cancer-related topic is addressed in order to assist people with cancer. A podcast can be listened to online (through the Internet) or downloaded to your computer free of charge. After downloading, a Cancer.Net Podcast may also be transferred to an MP3 audio player, such as an iPod. To download or listen to a Cancer.Net Podcast on your computer, you will need software capable of playing MP3 files, such as Windows Media Player or QuickTime.
You may also want to subscribe to Cancer.Net Podcasts, so that new offerings are automatically downloaded to your personal computer as soon as they are available. To subscribe, copy-and-paste the link below into software that allows podcast subscriptions, such as iTunes or Juice.
In this podcast, we discuss the news highlighted at ASCO's 2011 Annual Meeting that covers research on managing cancer as a chronic disease, and includes information on advances in treatment for lung cancer and gastrointestinal stromal tumor, as well as symptom management and survivorship care.
In this podcast, we discuss news highlighted at ASCO's 2011 Annual Meeting regarding melanoma and neuroblastoma.
In this podcast, we discuss news highlighted at ASCO's 2011 Annual Meeting regarding breast and ovarian cancers.
In this podcast, we discuss some of the news highlighted at ASCO's 2011 Annual Meeting regarding new drugs for melanoma and leukemia, selecting treatment for lung cancer, and predicting survival for men with prostate cancer.
In this podcast, we discuss news highlighted at ASCO's 2011 Annual Meeting regarding personalized medicine and childhood leukemia.
In March 2011, the Food and Drug Administration, or FDA, approved a medication called ipilimumab, or Yervoy, for the treatment of later-stage melanoma. To help explain the treatment risks and side effects is Lynn M. Schuchter, MD
A recording of the May 18, 2011 teleconference for patient advocates on the news coming out of the 2011 ASCO Annual Meeting. It includes a discussion of research on HPV testing for cervical cancer, screening and a new treatment for ovarian cancer, PSA testing for prostate cancer, predicting the risk of nerve damage from chemotherapy, treatment for advanced cancers, and the effects of smoking for women with a high risk of breast cancer.
In this podcast, we discuss dealing with workplace discrimination after a cancer diagnosis.
This podcast is led by ASCO member, Evan J. Lipson, MD. Dr. Lipson recently launched a website, called Seize the Days, that offers people with cancer and their families an opportunity to record and preserve audio interviews as a way to share their personal stories with others. In this podcast, Dr. Lipson discusses Seize the Days and provides stories from patients about how a cancer diagnosis affected their lives. ASCO would like to thank Dr. Lipson and his patients for sharing these stories.
In this podcast, ASCO's president, Dr. George Sledge, discusses advanced cancer care planning. Advanced cancer care is cancer that cannot be cured. It's also called end-stage cancer or terminal cancer. However, incurable does not mean untreatable, and people with advanced cancer still have treatment options. ASCO is working with oncologists to help patients and their families talk about advanced cancer to identify the best individual treatment plan for each patient.